Mary Nallin-Omstead

Statistics

Publications

Citations

481

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

United States Military Academy

Merck Biopharma Co., Ltd. (Japan)

Mary Nallin-Omstead is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, biochemistry, and enzyme inhibition.

Publications per year

1993–1997

Publications

Isolation and structure of chaetomellic acids A and B from Chaetomella acutiseta: farnesyl pyrophosphate mimic inhibitors of ras farnesyl-protein transferase

Sheo B. Singh, Deborah L. Zink, Jerrold M. Liesch et al. · Tetrahedron · 1993 · 93 citations

Life Sciences, Biochemistry, Pharmacology +5

Isolation and structure elucidation of viridiofungins A, B and C

Guy H. Harris, E. Tracy Turner Jones, María Meinz et al. · Tetrahedron Letters · 1993 · 59 citations

Pharmacy, Biochemistry, Medicinal Chemistry +6

Discovery of novel secondary metabolites from fungi—is it really a random walk through a random forest?

Richard L. Monaghan, Jon D. Polishook, Victor Pecore et al. · Canadian Journal of Botany · 1995 · 53 citations

Life Sciences, Biochemistry, Microbiology +17

Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protien transferase

R. B. Lingham, KeithC. Silverman, Gerald F. Bills et al. · Applied Microbiology and Biotechnology · 1993 · 52 citations

Life Sciences, Biochemistry, Pharmacology +6

Barceloneic Acid A, a New Farnesyl-Protein Transferase Inhibitor from a Phoma Species

Hiranthi Jayasuriya, Richard G. Ball, Deborah L. Zink et al. · Journal of Natural Products · 1995 · 51 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +5

1–5 of 11